SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001096906-23-000216
Filing Date
2023-01-27
Accepted
2023-01-27 14:18:09
Documents
1
Group Members
ANA PARKER

Document Format Files

Seq Description Document Type Size
1 ARCH THERAPEUTICS, INC. - 13GA arch_sc13ga.htm SC 13G/A 49552
  Complete submission text file 0001096906-23-000216.txt   50957
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Subject) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-87522 | Film No.: 23561820
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O NEXT PHASE ENTERPRISES 4020 NORTH 20TH STREET, SUITE 305 PHOENIX AZ 85016
Business Address
Parker Michael Andrew (Filed by) CIK: 0001653850 (see all company filings)

Type: SC 13G/A